Challenges in Assessing the Impact of the COVID-19 Pandemic on the Integrity and Interpretability of Clinical Trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Challenges in Assessing the Impact of the COVID-19 Pandemic on the Integrity and Interpretability of Clinical Trials

Published:2020-08-17 Issue:4 Volume:12 Page:419-426
ISSN:1946-6315
Container-title:Statistics in Biopharmaceutical Research
language:en
Short-container-title:Statistics in Biopharmaceutical Research

Author:

Akacha Mouna¹,Branson Janice¹,Bretz Frank¹²,Dharan Bharani³,Gallo Paul³,Gathmann Insa¹,Hemmings Robert⁴,Jones Julie¹,Xi Dong³^ORCID,Zuber Emmanuel¹

Affiliation:

1. Clinical Development & Analytics, Novartis Pharma, Basel, Switzerland;

2. Section for Medical Statistics, Medical University of Vienna, Vienna, Austria;

3. Clinical Development & Analytics, Novartis Pharmaceuticals, East Hanover, NJ;

4. CONSILIUM Salmonson & Hemmings, London, UK

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Statistics and Probability

Link

https://www.tandfonline.com/doi/pdf/10.1080/19466315.2020.1788984

Reference18 articles.

1. Estimands and Their Role in Clinical Trials

2. Estimands in clinical trials - broadening the perspective

3. Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer's Disease and Related Dementias

4. Assessing the Impact of the COVID-19 Pandemic and Accompanying Mitigation Efforts on Older Adults

5. EMA (2020a), “Guidance on the Management of Clinical Trials During the COVID-19 (Coronavirus) Pandemic,” available at https://www.ema.europa.eu/.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Possible data-generating models of longitudinal continuous outcomes and intercurrent events to investigate estimands;Statistics in Biopharmaceutical Research;2024-06-26

2. Comparative analysis of the adaptability of COVID-19 pandemic clinical trial protocols by several sponsors;Медицинская этика;2024-06

3. A qualitative study on the impacts of COVID-19 on the delivery of randomised controlled trials evaluating lay-delivered psychological interventions in five countries;SSM - Mental Health;2023-12

4. Challenges and solutions in clinical research during the COVID‐19 pandemic: A narrative review;Health Science Reports;2023-08

5. Adherence to Antiretrovirals and HIV Viral Suppression Under COVID-19 Pandemic Interruption – Findings from a Randomized Clinical Trial Using Ingestible Sensors to Monitor Adherence;AIDS and Behavior;2023-07-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3